Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths.
cause-specific mortality
comorbididites
death
demographics
symptom
tuberculosis
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
04
2023
accepted:
09
08
2023
medline:
19
9
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
epublish
Résumé
Tuberculosis (TB) is a major cause of ill health and one of the leading causes of death worldwide. The first step in developing strategies to reduce TB mortality is to identify the direct causes of death in patients with TB and the risk factors for each cause. Data on patients with TB systemically collected from the National Surveillance System of South Korea from January 2019 to December 2020 were included in this study. We analyzed the clinical characteristics associated with TB and non-TB-related deaths, including TB-related symptoms, comorbidities, and radiographic and microbiological findings. Of the total of 12,340 patients with TB, 61% were males with a mean age of 61.3 years. During the follow-up period, the overall mortality rate was 10.6%, with TB-related deaths accounting for 21.3% of all TB deaths. The median survival time in the TB-related death group was 22 days. TB-related death was associated with older age, lower body mass index (BMI), dyspnea, fever, general weakness, bilateral radiographic patterns, and acid-fast bacilli (AFB)-positive smears. Non-TB-related deaths were associated with older age, male sex, lower BMI, comorbidities of heart, liver, kidney, and central nervous system (CNS) diseases, CNS TB involvement, the presence of dyspnea, general weakness, and bilateral radiographic patterns. Patients with high-risk TB must be identified through cause-specific mortality analysis, and the mortality rate must be reduced through intensive monitoring of patients with a high TB burden and comorbidities.
Identifiants
pubmed: 37719730
doi: 10.3389/fpubh.2023.1207284
pmc: PMC10502314
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1207284Informations de copyright
Copyright © 2023 Jeong, Park, Kim, Min, Ko, Oh, Lee, Yang, Lee, Kim, Chang, Jegal, Lee, Kim and Koo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Tuberc Lung Dis. 2013 Jan;17(1):54-60
pubmed: 23232005
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):218-227
pubmed: 32610836
Int J Tuberc Lung Dis. 2006 Aug;10(8):857-63
pubmed: 16898369
Eur Respir J. 1998 Apr;11(4):816-20
pubmed: 9623682
Int J Tuberc Lung Dis. 2006 May;10(5):542-9
pubmed: 16704037
PLoS One. 2014 Mar 18;9(3):e92077
pubmed: 24642794
Int J Tuberc Lung Dis. 2006 Nov;10(11):1224-30
pubmed: 17131780
Thorax. 2018 Jan;73(1):70-77
pubmed: 28778918
Clin Microbiol Infect. 2019 Jun;25(6):761.e1-761.e7
pubmed: 30394362
Int J Tuberc Lung Dis. 2008 Mar;12(3):314-8
pubmed: 18284838
Int J Tuberc Lung Dis. 2001 Feb;5(2):113-22
pubmed: 11258504
BMC Infect Dis. 2014 Jan 03;14:5
pubmed: 24387757
Int J Tuberc Lung Dis. 2009 Mar;13(3):328-34
pubmed: 19275792
BMC Infect Dis. 2009 Jun 17;9:95
pubmed: 19531267
Chest. 2004 Oct;126(4):1079-86
pubmed: 15486367
Int J Tuberc Lung Dis. 2011 Jul;15(7):871-85
pubmed: 21496360
Int J Tuberc Lung Dis. 2007 Feb;11(2):143-9
pubmed: 17263283
Clin Infect Dis. 2002 Mar 15;34(6):752-9
pubmed: 11850859
Int J Tuberc Lung Dis. 2003 Aug;7(8):742-50
pubmed: 12921150
Intensive Care Med. 2001 Mar;27(3):513-20
pubmed: 11355119
PLoS One. 2020 Oct 8;15(10):e0240090
pubmed: 33031403
BMC Infect Dis. 2019 Aug 22;19(1):735
pubmed: 31438876
Eur Respir J. 2008 Jun;31(6):1256-60
pubmed: 18515556